Showing results (1881-1890 of 1,918) with videos related to
Sort By:
Pageof 192
The American Journal of Emergency Medicine|May 24, 2020
Management of acute ischemic stroke in patients with COVID-19 infection: Insights from an international panelAdnan I Qureshi, Foad Abd-Allah, Fahmi Al-Senani, et al.Journal of Atherosclerosis and Thrombosis|May 19, 2020
Renal Function-Dependent Associations of Statins with Outcomes of Ischemic StrokeShin-Joe Yeh, Sung-Chun Tang, Li-Kai Tsai, et al.Journal of the American College of Radiology : JACR|December 1, 2023
ACR Appropriateness Criteria® Congenital or Acquired Heart Disease, Rajesh Krishnamurthy, Garima Suman, et al.Neuro-Oncology|July 24, 2023
EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progressionArthur R Wolin, Melanie Y Vincent, Taylor Hotz, et al.ACS Synthetic Biology|May 23, 2018
Tuning Gene Activity by Inducible and Targeted Regulation of Gene Expression in Minimal Bacterial CellsAna M Mariscal, Shigeyuki Kakizawa, Jonathan Y Hsu, et al.International Journal of Stroke : Official Journal of the International Stroke Society|May 5, 2020
Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panelAdnan I Qureshi, Foad Abd-Allah, Fahmi Al-Senani, et al.Journal of the American Society of Nephrology : JASN|April 20, 2019
The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session DurationLaura M Dember, Eduardo Lacson, Steven M Brunelli, et al.Frontiers in Neurology|September 20, 2021
Smoking Status and Functional Outcomes in Young StrokeCheng-Loong Liang, Han-Jung Chen, Yi-Che Lee, et al.Atherosclerosis|February 16, 2015
Low estimated glomerular filtration rate is associated with poor outcomes in patients who suffered a large artery atherosclerosis strokeShin-Joe Yeh, Jiann-Shing Jeng, Sung-Chun Tang, et al.The Lancet. Oncology|August 13, 2019
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialCristina Saura, Dominik Hlauschek, Mafalda Oliveira, et al.Pageof 192